Navigation Links
Zinc Shows Promise Against Deadly Jellyfish Venom
Date:12/12/2012

WEDNESDAY, Dec. 12 (HealthDay News) -- A zinc compound could prove a lifesaver for people who suffer potentially deadly stings from the Australian box jellyfish, according to researchers who tried the treatment in mice.

The jellyfish are among the most venomous creatures in the world. Researchers have long tried to learn more about why the jellyfish's venom is so deadly and how to counter it.

In this study, researchers developed ways to extract venom from the jellyfish and tested it on human blood and on mice. They found that the venom rapidly punched holes in human red blood cells, making them leak large amounts of potassium. This leads to cardiac arrest and death.

Further research showed that a compound called zinc gluconate slowed the venom's ability to harm the red blood cells and increased survival time in mice exposed to the venom, according to the study, which was published December 12 in the journal PLoS One.

Scientists note, however, that research with animals often fails to provide similar results in humans.

"For over 60 years researchers have sought to understand the horrifying speed and potency of the venom of the Australian box jellyfish," study author Angel Yanagihara, of the University of Hawaii, said in a journal news release.

The new findings suggest that the venom's ability to boost potassium levels is what makes it so deadly, and that rapid treatment with zinc could save the lives of people stung by the jellyfish, said Yanagihara and colleagues.

More information

The CRC Reef Research Center in Australia has more about the Australian box jellyfish.

-- Robert Preidt

SOURCE: PLoS One, news release, Dec. 12, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Scientists ID Gene That Shows Progression in ALS Patients
2. Avastin Shows No Benefit for Earlier Colon Cancer: Study
3. Salmonella spreads by targeting cells in our gut, study shows
4. Intensified chemotherapy shows promise for children with very high risk form of leukemia
5. New multiple myeloma drug shows promise in treating people with advanced disease
6. Study of text messaging service shows participants prepared for motherhood
7. Survey shows breakthrough medical research relies heavily on NIH funding
8. Brain study shows why some people are more in tune with what they want
9. Pre-clinical data shows Angiocidin effective against leukemia
10. UC Davis study shows that treadmill testing can predict heart disease in women
11. New poll shows US public supports continued investment in Federal Nutrition Assistance Program
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Zinc Shows Promise Against Deadly Jellyfish Venom 
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... inspirational interview of two ostomy patients, standing as living proof that attitude and ... from digestive diseases and issues that spike around the holidays. This campaign will ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic technologies, ... while maintaining fulfilling lives. “We are prolonging life 6 years in the last ...
(Date:12/2/2016)... OH (PRWEB) , ... December 02, 2016 , ... ... of veterinarian diagnostic imaging systems and the first company to offer ... With a Heart at their tradeshow booth # 941 for the American Association ...
(Date:12/2/2016)... ... 02, 2016 , ... Yisrayl Hawkins, at The House of Yahweh in Abilene, ... into Bible Prophecy. Yisrayl says this generation, known as the Last Generation, started in ... the details line up exactly with Bible Prophecy – a protected way for those ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 1, 2016  Today, Simpson Healthcare Executives, ... honor of being selected as winners of multiple awards ... Executives Website at the PLATINUM level, Blue Zones Menu ... at the GOLD Level, and our proprietary 3ConneX Platform ... Simpson Healthcare Executives, we are excited to showcase our ...
(Date:12/2/2016)... BRUSSELS , Dec. 2, 2016  UCB is pleased to ... presentation at the upcoming 70 th American Epilepsy Society ... Houston, TX , USA. 1-12 ... safety and efficacy profile of VIMPAT ® (lacosamide) CV ... also share findings on the current state of the union ...
(Date:12/2/2016)... Dec. 2, 2016 Allergan plc (NYSE: ... information on its previously announced Accelerated Share Repurchase (ASR) Program. ... ... As previously announced, the Company entered into a ... the Company will repurchase $10 billion of its ordinary shares. ...
Breaking Medicine Technology: